Please login to the form below
pricing
This page shows the latest pricing news and features for those working in and with pharma, biotech and healthcare.
Biogen plans confirmatory trial as FDA documents show struggle over Aduhelm approval
to address pricing in order to achieve both patient access and support budget sustainability.”.
Latest news
-
ICER to review the role of health insurers in determining patient access to prescription drugs
coverage for drugs and, in addition, promote the positive linkage of fair pricing with fair access that will advance the best interests of patients and the health system.'.
-
Pharma marketers’ blog: How to prioritise, perform and prevail
Consider if pricing/value/access or segmentation/technology skills/ promotional mix are most important.
-
W2O rebrands as ‘health innovation company’ Real Chemistry
The company combines services in digital marketing, creative and communications with clinical trial, health economics and outcomes, as well as value, pricing and access advisory expertise.
-
Pfizer/BioNTech reach vaccine supply agreement with COVAX
Ghebreyesus urged countries with bilateral contracts to provide transparency on these deals with COVAX – including on volumes, pricing and delivery dates.
-
WHO’s director-general deems vaccine nationalism a “catastrophic moral failure”
Ghebreyesus has now called on countries with bilateral contracts to provide transparency on these deals with COVAX – including on volumes, pricing and delivery dates.
ICER to review the role of health insurers in determining patient access to prescription drugs
Pharma marketers’ blog: How to prioritise, perform and prevail
W2O rebrands as ‘health innovation company’ Real Chemistry
Pfizer/BioNTech reach vaccine supply agreement with COVAX
WHO’s director-general deems vaccine nationalism a “catastrophic moral failure”
More from news
Approximately 108 fully matching, plus 902 partially matching documents found.
Latest Intelligence
-
Communicating for change – creating effective medical communications
to support initial pricing and market access considerations for forecasting, product value, positioning options and patient segmentation?
-
Pre-launch planning and DSLs – the new ways to create launch excellence in pharma
efficacy, safety, pricing, medicine administration). Test messaging and language. o Engage and learn from the online community (without mentioning your product).
-
Piloting a route to the biosimilars opportunities in Europe
The increased competition also forces originator/biologic manufacturers and sellers to reduce the pricing of their innovative products, further adding to the affordability of important treatments. ... and. lead to supply shortages), to fixed
-
Product launches: making the most of your one shot
So why does it go wrong so often? There are many potential reasons, including a lack of engagement with key medical and payer stakeholders, an inadequate pricing and market access strategy
-
Market shaping for better healthcare decisions
economic modelling and a global pricing structure.
Communicating for change – creating effective medical communications
Pre-launch planning and DSLs – the new ways to create launch excellence in pharma
Piloting a route to the biosimilars opportunities in Europe
Product launches: making the most of your one shot
Market shaping for better healthcare decisions
More from intelligence
Approximately 16 fully matching, plus 195 partially matching documents found.
Latest appointments
-
New faces at Lucid Group and ZPB Associates
Most recently, she worked in the consultancy’s rare diseases division, where is provided crisis management support in pricing/access barriers for an orphan drug.
-
New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare
Both O’Leary and Massey have experience of delivering evidence-based pricing and market access communications to help build global brands.
-
New faces at GCI Health, Porterhouse Medical and Research Partnership
Meanwhile Emma Warburton joins the agency as business development executive after previously working as a pricing and market research analyst.
-
BMS appoints new commercial leader, Davies joins Eisai and more
She will also oversee marketing, pricing, forecasting and analytics. Brian Hoffmann, president of Hikma’s generics division, said: “I am looking forward to working closely with Kristy and her team to
-
Weekly comms appointments
Pyati’s new domain will see him grow and expand the group’s scientific and medical communications practice and integrating it with the firm’s analytics, digital and value, pricing and
New faces at Lucid Group and ZPB Associates
New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare
New faces at GCI Health, Porterhouse Medical and Research Partnership
BMS appoints new commercial leader, Davies joins Eisai and more
Weekly comms appointments
More from appointments
Approximately 2 fully matching, plus 31 partially matching documents found.
Latest from PMHub
-
Market Access Transformation (MAT) Secures First Institutional Funding Led by Silversmith Capital Partners
While RPR has enabled us to deliver technology solutions to a wide variety of pharma companies across the globe, our expert team of pricing and market access specialists drive client engagement
-
Market Shaping for Better Healthcare Decisions
economic modelling and a global pricing structure.
-
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Read on. LAUNCHING HAS NEVER BEEN EASY. Growing competition, pricing pressures, and shifting expectations of stakeholders has meant that launches have failed to meet forecasts.
-
Fishawack Health unveils an unrivaled global market access and HEOR offering with the acquisition of PRMA Consulting
We’re delighted to add a team of market access and health economics strategists with deep specialism in HEOR, healthcare technology assessments, pricing, and reimbursement processes.”.
-
Why you must understand the pricing of patient recruitment companies
that. Honestly we do. It’s time to talk about this and go deeper into the pricing of these services that you might rely on for help.
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Why you must understand the pricing of patient recruitment companies
More from PMHub
Approximately 6 fully matching, plus 66 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Omnichannel Strategy Consultant
-
Competitive Salary
-
CEO Pricing & Market Access, UK
-
Six figure salary
-
CEO, Head of Health, UK
-
Six figure salary
-
Senior Account Manager
-
Competitive salary offered
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Biosimilars boosted by FDA's landmark ruling for Boehringer’s Cyltezo
- US demand for COVID-19 antibody treatments rising fast
- Valneva COVID-19 vaccine more effective than AZ
- EU “still interested” in Valneva COVID vaccine despite UK snub
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Call for industry innovators to join working group
- Pfizer-BioNTech booster offers 95.6% efficacy against COVID-19
- US COVID-19 booster programme expanded
- The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
- Mind the Gap – Challenging Immunisation Apathy and Misinformation
- Towards Better HCP Engagement – An Email Masterclass
- Engaging HCPs on their own terms: how pharma can adapt to the post-pandemic digital era
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Beyond yoga and smoothies – providing real support for employee well-being
- The Future of eHealth: Contactless Health Monitoring
- Reckitt to spin-off pharma unit as Indivior
- Results of AstraZeneca’s TACKLE phase 3 trial show antibody combination reduces risk of severe COVID-19 or death
PMHub
Lucid Group Communications Limited
WE’RE ON A MISSION
To transform lives through communication that changes behaviour and improves health outcomes....
Latest intelligence
- The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
- The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
- Mind the Gap – Challenging Immunisation Apathy and Misinformation
- world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
- Towards Better HCP Engagement – An Email Masterclass
- 6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....
